Trial
NCT04865458
A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sunshine Lake Pharma Co., Ltd.
Collaborators
—
Condition
Relapsed or Refractory B-cell Hematologic Malignancies
Intervention
HEC89736
Why stopped
Adjustment to the sponsor's development strategy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-14